semaglutide subcutaneous How To Inject Safely Prescribing | Ozempic® (semaglutide) injection

Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways

Clinicians should: Assess baseline HbA1c and current glycemic control before discontinuation Implement or intensify alternative therapies (metformin, SGLT2 inhibitors, or other agents) before or concurrent with tirzepatide cessation Increase home glucose monitoring frequency for several weeks post-discontinuation Schedule follow-up to evaluate metabolic stability Special consideration for insulin or sulfonylurea users : Patients taking these medications alongside tirzepatide may need proactive dose adjustments when stopping tirzepatide to prevent hypoglycemia

Your healthcare provider will determine the optimal duration based on your progress, tolerance, and goals

Patients and physicians are both learning of various benefits and off-label indications for this group of medications, referred to as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

And when progress slows, patients look elsewhere